{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:35Z","timestamp":1786628255429,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Pfizer Pharmaceutical Israel, Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-026-03358-7","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:45:39Z","timestamp":1779324339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary care physicians\u2019 perspectives on managing mild-to-moderate COVID-19 in populations at risk for progression to severe disease: a survey-based study"],"prefix":"10.1186","volume":"27","author":[{"given":"Carmel","family":"Kasher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Distelman-Menachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Bareket-Samish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-5722","authenticated-orcid":false,"given":"Shirley","family":"Shapiro Ben David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"10316","key":"3358_CR1","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/S0140-6736(21)01897-3","volume":"398","author":"S Singh","year":"2021","unstructured":"Singh S, McNab C, Olson RM, Bristol N, Nolan C, Bergstrom E, et al. How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic. Lancet. 2021;398(10316):2109\u201324.","journal-title":"Lancet"},{"key":"3358_CR2","unstructured":"World Health Organization. COVID-19 dashboard. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"issue":"5","key":"3358_CR3","first-page":"271","volume":"22","author":"E Itelman","year":"2020","unstructured":"Itelman E, Wasserstrum Y, Segev A, Avaky C, Negru L, Cohen D, et al. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary report from a large tertiary center. Isr Med Assoc J. 2020;22(5):271\u20134.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"3358_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12985-023-01973-9","volume":"20","author":"Y Panahi","year":"2023","unstructured":"Panahi Y, Gorabi AM, Talaei S, Beiraghdar F, Akbarzadeh A, Tarhriz V, et al. An overview on the treatments and prevention against COVID-19. Virol J. 2023;20(1):23.","journal-title":"Virol J"},{"issue":"2","key":"3358_CR5","doi-asserted-by":"publisher","first-page":"e0310611","DOI":"10.1371\/journal.pone.0310611","volume":"20","author":"TK Gebretekle","year":"2025","unstructured":"Gebretekle TK, Albers C. Modelling the impact of behavioural interventions during pandemics: a systematic review. PLoS ONE. 2025;20(2):e0310611.","journal-title":"PLoS ONE"},{"issue":"4","key":"3358_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/pubmed\/fdab055","volume":"43","author":"S Shapiro Ben David","year":"2021","unstructured":"Shapiro Ben David S, Cohen D, Karplus R, Irony A, Ofer-Bialer G, Potasman I, et al. COVID-19 community care in Israel - a nationwide cohort study from a large health maintenance organization. J Public Health (Oxf). 2021;43(4):723\u201330.","journal-title":"J Public Health (Oxf)"},{"key":"3358_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123610","volume":"371","author":"M Azeem","year":"2025","unstructured":"Azeem M, Cancemi P, Mukhtar F, Marino S, Peri E, Di Prima G, et al. Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review. Life Sci. 2025;371:123610.","journal-title":"Life Sci"},{"key":"3358_CR8","unstructured":"Veklury\u00a0[package insert]. Foster City, CA: Gilead Sciences, Inc.; 2024."},{"key":"3358_CR9","unstructured":"Paxlovid [package insert]. New York, NY: Pfizer Inc.; 2025."},{"key":"3358_CR10","unstructured":"Infectious Diseases Society of America (IDSA). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Last updated June 26, 2023. Available from: https:\/\/www.idsociety.org\/globalassets\/idsa\/practice-guidelines\/covid-19\/treatment\/idsa-covid-19-gl-tx-and-mgmt-v11.0.0.pdf."},{"key":"3358_CR11","unstructured":"Israeli Ministry of Health. Recommendations for patients with confirmed COVID-19. Available from: https:\/\/corona.health.gov.il\/confirmed-cases-and-patients\/recommendations\/."},{"key":"3358_CR12","unstructured":"Digital antimicrobial guidelines (Israel). Guidelines for offering antiviral medication for COVID-19 patients. Available from: https:\/\/soroka.dag.msd.co.il\/."},{"key":"3358_CR13","unstructured":"University of Liverpool. COVID-19 drug interaction checker. Available from: https:\/\/www.covid19-druginteractions.org\/."},{"issue":"6","key":"3358_CR14","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s10900-020-00882-0","volume":"45","author":"WY Abdel Wahed","year":"2020","unstructured":"Abdel Wahed WY, Hefzy EM, Ahmed MI, Hamed NS. Assessment of knowledge, attitudes, and perception of health care workers regarding COVID-19, a cross-sectional study from Egypt. J Community Health. 2020;45(6):1242\u201351.","journal-title":"J Community Health"},{"issue":"1","key":"3358_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.aucc.2021.04.008","volume":"35","author":"S Nahidi","year":"2022","unstructured":"Nahidi S, Sotomayor-Castillo C, Li C, Currey J, Elliott R, et al. Australian critical care nurses\u2019 knowledge, preparedness, and experiences of managing SARS-COV-2 and COVID-19 pandemic. Aust Crit Care. 2022;35(1):22\u20137.","journal-title":"Aust Crit Care"},{"key":"3358_CR16","doi-asserted-by":"crossref","unstructured":"Maruf MA, Weng YH, Lee MH, Lee KY, Wu MS, Bui C et al. Knowledge, attitudes, and practices of health care personnel toward COVID-19 pandemic in Taiwan, Vietnam, and Indonesia. Asia Pac J Public Health. 2025;37(6\u20137):578\u201385.","DOI":"10.1177\/10105395251371250"},{"issue":"10","key":"3358_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.5005\/jp-journals-10071-23567","volume":"24","author":"SS Maddani","year":"2020","unstructured":"Maddani SS, Chaudhuri S, Deepa HC, Amara V. A multicenter questionnaire-based study to know the awareness and medical treatment plan of physicians involved in the management of COVID-19 patients. Indian J Crit Care Med. 2020;24(10):919\u201325.","journal-title":"Indian J Crit Care Med"},{"issue":"8","key":"3358_CR18","doi-asserted-by":"publisher","first-page":"e2331249","DOI":"10.1001\/jamanetworkopen.2023.31249","volume":"6","author":"L Yan","year":"2023","unstructured":"Yan L, Streja E, Li Y, Rajeevan N, Rowneki M, Berry K, et al. Anti-SARS-CoV-2 pharmacotherapies among nonhospitalized US veterans, January 2022 to January 2023. JAMA Netw Open. 2023;6(8):e2331249.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"3358_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.15585\/mmwr.mm7303a2","volume":"73","author":"PA Monach","year":"2024","unstructured":"Monach PA, Anand ST, Fillmore NR, La J, Branch-Elliman W. Underuse of antiviral drugs to prevent progression to severe COVID-19 - Veterans Health Administration, March-September 2022. MMWR Morb Mortal Wkly Rep. 2024;73(3):57\u201361.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"3358_CR20","doi-asserted-by":"publisher","first-page":"e235044","DOI":"10.1001\/jamahealthforum.2023.5044","volume":"5","author":"AD Wilcock","year":"2024","unstructured":"Wilcock AD, Kissler S, Mehrotra A, McGarry BE, Sommers BD, Grabowski DC, et al. Clinical risk and outpatient therapy utilization for COVID-19 in the Medicare population. JAMA Health Forum. 2024;5(1):e235044.","journal-title":"JAMA Health Forum"},{"issue":"12","key":"3358_CR21","doi-asserted-by":"publisher","first-page":"ofae666","DOI":"10.1093\/ofid\/ofae666","volume":"11","author":"JB Singleton","year":"2024","unstructured":"Singleton JB, Wang D, Louis S, Smith DJ, Lambrou AS, Beekmann SE, et al. Perceptions and barriers to outpatient antiviral therapy for COVID-19 and influenza as observed by infectious disease specialists in North America: results of an Emerging Infections Network (EIN) survey, February 2024. Open Forum Infect Dis. 2024;11(12):ofae666.","journal-title":"Open Forum Infect Dis"},{"issue":"147","key":"3358_CR22","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1017\/S0950268819001407","volume":"25","author":"T Kalish","year":"2019","unstructured":"Kalish T, Miron D, Azrad M, Rechnitzer H, Ben-Amram H, Glikman D, et al. Characteristics of hospitalised patients with influenza in 2015\u20132016 in northern Israel: three circulating strains and continued fear of 2009 A\/H1N1. Epidemiol Infect. 2019;25(147):e278.","journal-title":"Epidemiol Infect"},{"key":"3358_CR23","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1186\/s12889-024-19687-0","volume":"24","author":"SEAM Soh","year":"2024","unstructured":"Soh SEAM, Ong WLB, Thein T-L, Griva K, Chen I-CM. Insights from a community-based survey on factors influencing acceptance and uptake of Paxlovid (nirmatrelvir and ritonavir) as a COVID-19 antiviral medication in Singapore. BMC Public Health. 2024;24:2332.","journal-title":"BMC Public Health"},{"key":"3358_CR24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s11739-021-02884-9","volume":"17","author":"M Coen","year":"2022","unstructured":"Coen M, Sader J, Junod-Perron N, Aud\u00e9tat M-C, Nendaz M. Clinical reasoning in dire times. Analysis of cognitive biases in clinical cases during the COVID-19 pandemic. Intern Emerg Med. 2022;17:979\u201388.","journal-title":"Intern Emerg Med"},{"key":"3358_CR25","doi-asserted-by":"publisher","first-page":"e0256806","DOI":"10.1371\/journal.pone.0256806","volume":"16","author":"G Salvato","year":"2021","unstructured":"Salvato G, Ovadia D, Messina A, Bottini G. Health emergencies and interoceptive sensibility modulate the perception of non-evidence-based drug use: findings from the COVID-19 outbreak. PLoS ONE. 2021;16:e0256806.","journal-title":"PLoS ONE"},{"key":"3358_CR26","doi-asserted-by":"publisher","first-page":"105772","DOI":"10.1016\/j.ijmedinf.2024.105772","volume":"195","author":"M Jammal","year":"2025","unstructured":"Jammal M, Saab A, Abi Khalil C, Mourad C, Tsopra R, Saikali M, et al. Impact on clinical guideline adherence of Orient-COVID, a clinical decision support system based on dynamic decision trees for COVID19 management: A randomized simulation trial with medical trainees. Int J Med Inform. 2025;195:105772.","journal-title":"Int J Med Inform"},{"key":"3358_CR27","doi-asserted-by":"crossref","unstructured":"Munteanu A, Lighezan DF, Rosca MS, Otiman G, Nicoras VA, Nistor D et al. The family doctor in the \u201cCOVID-19 Era\u201d. Healthcare (Basel). 2024;13(1):32.","DOI":"10.3390\/healthcare13010032"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-026-03358-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03358-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03358-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:03:37Z","timestamp":1786626217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12875-026-03358-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3358"],"URL":"https:\/\/doi.org\/10.1186\/s12875-026-03358-7","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Physicians who took part in this survey had previously registered on the Medic website and agreed to receive messages, including surveys. The data were handled in compliance with applicable data protection regulations. Since all the data were anonymized, no informed consent was required. The survey was non-interventional and did not provide clinical data; hence, ethics approval was not required. The study was conducted in accordance with the Declaration of Helsinki. The Survey was conducted by an external company, and no authors were involved in the process of data collection, and data analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TDM is employed by Pfizer Pharmaceuticals. CK, ABS, and SBD have received consulting fees from Pfizer Pharmaceuticals.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"304"}}